Home > PJ (current issue) > Reviews | Search

The Pharmaceutical Journal
Vol 273 No 7315 p327
4 September 2004

Books

Useful reference source but probably tries to do too many different things

Dictionary of pharmacovigilance’, by Amer Alghabban. Pp ix+527. Price £39.95. London: Pharmaceutical Press; 2004. ISBN 0 85369 516 4


Dictionary of pharmacovigilancePharmacovigilance is a growing and expanding discipline with much associated and sometimes confusing terminology. This new dictionary provides definitions or descriptions, some with references, for over 3,100 abbreviations, terms and phrases relevant to the subject. It provides good coverage and explanations of day-to-day pharmacovigilance terms and there is a comprehensive listing of EU and Food and Drug Administration regulations, directives and terminology together with International Committee on Harmonisation documents. Some country-specific abbreviations and terms are also included. A number of adverse drug reaction (ADR) terms are also described but, since ADRs mimic a vast range of diseases, symptoms and signs, this is of relatively limited value because it is not a medical dictionary or textbook of medicine.

The numerous abbreviations and their meanings might be better separated from the other terms because, for most, there is no further explanation. Many are useful but some appear rather odd or perhaps company- or regulatory agency-specific, eg, CCS — Clinical Coding Specialist, HAR — Herbal Adverse Reaction, HL7 — Health Level 7, HSRC — Human Subjects Review Committee, and SRPF — Spontaneous Report Pregnancy Form. The size of the print is also small.

Overall, this is a useful reference source for anyone working in pharmacovigilance to have available and for the non-specialist it provides some good concise explanations with pointers to further reading. However, it probably tries to do too many different things, being a dictionary of pharmacovigilance terms, a dictionary of the more important ADRs and a list of abbreviations.


John C. C. Talbot

Correction
The price of the ‘Dictionary of pharmacovigilance’ is £65, not as stated.

Back to Top

John Talbot is director, Global Drug Safety, AstraZeneca R & D


©The Pharmaceutical Journal